After European regulators signed off on the deal, Australian regulators rejected a proposal by Google to assuage concerns about its proposed acquisition of Fitbit. They will continue their investigation of the merger through the end of March.
The suit, filed Wednesday in federal court by more than four dozen attorneys general, accuses 26 generic drug companies and 10 executives of keeping prices artificially high for the drugs. It is the third in a series of antitrust lawsuits targeting the industry.
Your varicose or spider veins may indicate an underlying problem, so finding the right vein specialist is crucial. Discover the best vein clinics in Orlando.
In a joint statement, FDA Commissioner Stephen Hahn and FTC Chairman Joseph Simons said they would look into anticompetitive practices like preventing biosimilar makers from obtaining product samples and misleading communications about biosimilars' safety and efficacy.
After the California Attorney General brought complaints of anticompetitive behavior against Sutter Health, the Sacramento-based health system will pay $575 million in a settlement.
Federal regulators said they would seek to block the acquisition deal amid concerns that Illumina was seeking to eliminate PacBio as a competitor in the next-generation sequencing space.
The Louisville-based insurer broke its long-standing no comment policy, citing "significant investor speculation and persistent market rumors."
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
The Department of Justice has weighed in on Oscar Health's side arguing that the antitrust concerns raised by the company in court should not be thrown out and backing Oscar's claims of "coercion" in the implementation of Florida Blue's exclusive broker policy.
Judge Amy Berman Jackson of the U.S. District Court for the District of Columbia issued the decision late Wednesday.
California Insurance Commissioner Dave Jones urged federal officials to block the merger of health insurance giants Anthem Inc. and Cigna Corp., declaring the $54-billion deal anti-competitive and harmful to consumers. The state insurance department doesn’t have the authority to thwart the merger on its own, but Jones’ recommendation Thursday could carry considerable weight in Washington […]
A year and a half ago, a federal judge invalidated the purchase of Nampa, Idaho-based Saltzer Medical Group by St. Luke’s Health System in nearby Boise, on antitrust grounds. A new review of documents from that case by the Idaho Statesman newspaper revealed a fine example of what Congress and the Department of Health and Human Services have dubbed "information blocking":
A new independent study from Phyx Primary Care’s Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices.
Last week's news that mega-health insurer Anthem has agreed to acquire fellow mega-health insurer Cigna for $48.4 billion has created quite a stir, especially since two more giants, Aetna and Humana had announced just three weeks earlier that they would merge for $37 billion.